Eileen Cowan1, Prathima Nandivada, Mark Puder. 1. Department of Surgery and the Vascular Biology Program, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA.
Abstract
PURPOSE OF REVIEW: Parenteral nutrition-associated liver disease (PNALD) is a major cause of morbidity and mortality in the parenteral nutrition-dependent population. Here, we review the most recent literature involving a fish oil-based lipid emulsion (FOLE) and its effects on PNALD. RECENT FINDINGS: Vegetable oil-based lipid emulsions (VBLEs) contribute to PNALD. This may be due to parenteral phytosterols and/or the presence of pro-inflammatory mediators. Whereas a small reduction in the dose of VBLE does not appear to prevent PNALD, a significant reduction in the dose may reverse PNALD; however, it carries the risk of essential fatty acid deficiency. Furthermore, the impact of extreme lipid restriction on subsequent neurodevelopment is unknown. Combination lipid emulsions containing fish oil are associated with decreased bilirubin levels, though no studies compare these emulsions with the outcomes with FOLE alone. The utility of FOLE in the reversal of PNALD has been demonstrated and its administration does not lead to essential fatty acid deficiency. Furthermore, there is evidence that FOLE may prevent PNALD. CONCLUSION: FOLE appears to be an efficacious treatment to reverse PNALD. However, more studies are necessary to determine if FOLE might also be beneficial in the prevention of PNALD. Future studies should additionally focus on the preterm infant population, as they represent a major population requiring parenteral nutrition support for survival.
PURPOSE OF REVIEW: Parenteral nutrition-associated liver disease (PNALD) is a major cause of morbidity and mortality in the parenteral nutrition-dependent population. Here, we review the most recent literature involving a fish oil-based lipid emulsion (FOLE) and its effects on PNALD. RECENT FINDINGS:Vegetable oil-based lipid emulsions (VBLEs) contribute to PNALD. This may be due to parenteral phytosterols and/or the presence of pro-inflammatory mediators. Whereas a small reduction in the dose of VBLE does not appear to prevent PNALD, a significant reduction in the dose may reverse PNALD; however, it carries the risk of essential fatty acid deficiency. Furthermore, the impact of extreme lipid restriction on subsequent neurodevelopment is unknown. Combination lipid emulsions containing fish oil are associated with decreased bilirubin levels, though no studies compare these emulsions with the outcomes with FOLE alone. The utility of FOLE in the reversal of PNALD has been demonstrated and its administration does not lead to essential fatty acid deficiency. Furthermore, there is evidence that FOLE may prevent PNALD. CONCLUSION: FOLE appears to be an efficacious treatment to reverse PNALD. However, more studies are necessary to determine if FOLE might also be beneficial in the prevention of PNALD. Future studies should additionally focus on the preterm infant population, as they represent a major population requiring parenteral nutrition support for survival.
Authors: T Hang Nghiem-Rao; Laura D Cassidy; Elizabeth M Polzin; Casey M Calkins; Marjorie J Arca; Praveen S Goday Journal: Nutr Clin Pract Date: 2013-10-09 Impact factor: 3.080
Authors: T Hang Nghiem-Rao; Ilker Tunc; Alisha M Mavis; Yumei Cao; Elizabeth M Polzin; Mary F Firary; Xujing Wang; Pippa M Simpson; Shailendra B Patel Journal: Pediatr Res Date: 2015-04-21 Impact factor: 3.756
Authors: Amanda R Hall; Ha Le; Chris Arnold; Janet Brunton; Robert Bertolo; Grant G Miller; Gordon A Zello; Consolato Sergi Journal: Nutrients Date: 2018-06-04 Impact factor: 5.717